1. Complete Response to PD-1 Inhibitor in Primary Hepatocellular Carcinoma Patients Post-Progression on Bi-Specific Antibody Conjugated CIK Cell Treatment: A Report of Two Cases
   Tong Wu et al, 2021, OncoTargets and Therapy CrossRef
2. MiR-374b-5p Regulates T Cell Differentiation and Is Associated with rEg.P29 Immunity
   Dongjie Li et al, 2020, BioMed Research International CrossRef
3. Application of adoptive cell therapy in hepatocellular carcinoma
   Dengqiang Wu et al, 2023, Immunology CrossRef
4. Increased both PD–L1 and PD–L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis
   Hidetaka Yasuoka et al, 2020, Scientific Reports CrossRef
5. The Regulatory Effects of MicroRNAs on Tumor Immunity
   Yan Lu et al, 2022, BioMed Research International CrossRef
6. The Role of NcRNAs to Regulate Immune Checkpoints in Cancer
   Yicun Jiang et al, 2022, Frontiers in Immunology CrossRef
7. PD-1/PD-L1 axis in organ fibrosis
   Youliang Zhao et al, 2023, Frontiers in Immunology CrossRef
8. mmu-miR-374b-5p modulated inflammatory factors via downregulation of C/EBP β/NF-κB signaling in Kupffer cells during Echinococcus multilocularis infection
   Guiting Pu et al, 2024, Parasites & Vectors CrossRef
9. Regulation of Immune Cells by microRNAs and microRNA-Based Cancer Immunotherapy
   Rafaela Nasser Veiga et al, 2022, Systems Biology of MicroRNAs in Cancer CrossRef